Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.
Ursini-Siegel
Josie
J
Goodman Cancer Centre and Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
Cory
Sean
S
Zuo
Dongmei
D
Hardy
William R
WR
Rexhepaj
Elton
E
Lam
Sonya
S
Schade
Babette
B
Jirstrom
Karin
K
Bjur
Eva
E
Piccirillo
Ciriaco A
CA
Denardo
David
D
Coussens
Lisa M
LM
Brennan
Donal J
DJ
Gallagher
William M
WM
Park
Morag
M
Pawson
Tony
T
Hallett
Michael
M
Muller
William J
WJ